A new study from the Netherlands highlights the cautious stance of physicians towards using mobile health apps with artificial intelligence for skin cancer assessment. Concerns include misdiagnosis, exclusion of vulnerable patients, and disruption of clinical care. While potential benefits were recognized, endorsement would depend on accurate testing, seamless integration into clinical practice, and accessibility to diverse users.

Source: BMC